Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 984 entries
View as:

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT05469789 Org: User:
Start: 06/29/23 End: 12/31/26 Due: 12/31/27

A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis

Phase: N/A Priority: Normal
NCT ID: NCT06443502 Org: User:
Start: 11/19/24 End: 12/31/29 Due: 12/31/30

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT05899673 Org: User:
Start: 08/08/23 End: 05/02/33 Due: 05/02/34

Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00760864 Org: User:
Start: 08/31/04 End: 09/30/05 Due: 09/30/06

Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants

Phase: N/A Priority: Normal
NCT ID: NCT01391663 Org: User:
Start: 07/31/11 End: 09/30/11 Due: 09/30/12

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04999839 Org: User:
Start: 08/11/21 End: 09/12/22 Due: 09/12/23

Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants

Phase: N/A Priority: Normal
NCT ID: NCT03281577 Org: User:
Start: 01/02/18 End: 07/12/19 Due: 07/12/20

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01637935 Org: User:
Start: 07/31/04 End: 08/31/14 Due: 08/31/15

A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice

Phase: N/A Priority: Normal
NCT ID: NCT03532932 Org: User:
Start: 07/20/18 End: 11/08/21 Due: 11/08/22

Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01318070 Org: User:
Start: 11/30/07 End: 10/31/08 Due: 10/31/09

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06243731 Org: User:
Start: 05/30/25 End: 01/31/27 Due: 01/31/28

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Phase: N/A Priority: Normal
NCT ID: NCT03209518 Org: User:
Start: 03/18/16 End: 10/10/18 Due: 10/10/19

A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05803200 Org: User:
Start: 03/15/23 End: 04/14/23 Due: 04/14/24

A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada

Phase: N/A Priority: Normal
NCT ID: NCT05578417 Org: User:
Start: 06/15/23 End: 06/30/24 Due: 06/30/25

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

Phase: N/A Priority: Normal
NCT ID: NCT00247390 Org: User:
Start: 07/31/05 End: 12/31/06 Due: 12/31/07

Validation Study of Physical Measurement of Tophi

Phase: N/A Priority: Normal
NCT ID: NCT00175006 Org: User:
Start: 11/30/02 End: 01/31/03 Due: 01/31/04

Phase 1 Bioavailability Study of SYR-322MET

Phase: N/A Priority: Normal
NCT ID: NCT02508168 Org: User:
Start: 04/30/16 End: 04/30/16 Due: 04/30/17

Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00174915 Org: User:
Start: 02/28/03 End: 04/30/04 Due: 04/30/05

A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

Phase: N/A Priority: Normal
NCT ID: NCT06377228 Org: User:
Start: 06/13/25 End: 09/02/30 Due: 09/02/31

A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema

Phase: N/A Priority: Normal
NCT ID: NCT05466747 Org: User:
Start: 01/01/24 End: 05/07/29 Due: 05/07/30

A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02063854 Org: User:
Start: 02/28/14 End: 11/30/15 Due: 11/30/16

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT02153112 Org: User:
Start: 06/23/15 End: 06/20/18 Due: 06/20/19

A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

Phase: N/A Priority: Normal
NCT ID: NCT02790138 Org: User:
Start: 10/12/16 End: 02/02/21 Due: 02/02/22

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT04779320 Org: User:
Start: 04/30/22 End: 05/22/26 Due: 05/22/27

ADYNOVATE Drug Use-Results Survey

Phase: N/A Priority: Normal
NCT ID: NCT03169972 Org: User:
Start: 02/01/17 End: 09/15/23 Due: 09/15/24